Background Emerging and future SARS-CoV-2 variants may jeopardize the effectiveness of
vaccination campaigns. Therefore, it is important to know how the different vaccines perform …

Emerging SARS-CoV-2 variants of concern (VOCs) pose a threat to human immunity induced
by natural infection and vaccination. We assessed the recognition of three VOCs (B.1.1.7, B…

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …

Next-generation sequencing (NGS) has instigated the research on the role of the microbiome
in health and disease. The compositional nature of such microbiome datasets makes it …

Background Vaccination of lactating women against COVID-19 may protect not only
themselves but also their breastfed infant through human milk. Therefore, it is important to gain …

COVID-19 patients produce circulating and mucosal antibodies. In adults, specific saliva
antibodies have been detected. Nonetheless, seroprevalence is routinely investigated, while …

The urgent need for, but limited availability of, SARS-CoV-2 vaccines worldwide has led to
widespread consideration of dose-sparing strategies. Here, we evaluate the SARS-CoV-2-…

Current SARS-CoV-2 vaccines are effective, but long-term protection is threatened by the
emergence of virus variants. We generated a virosome vaccine containing the Beta spike …

Background Antibiotic resistance is a major global public health threat. Antibiotic use can
directly impact the antibiotic resistant genes (ARGs) profile of the human intestinal microbiome …

The emergence of SARS-CoV-2 variants that are more resistant to antibody-mediated
neutralization pose a new hurdle in combating the COVID-19 pandemic. Although vaccines based …